Rheos Capital Works’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.1M Sell
47,500
-52,000
-52% -$11.6M 0.68% 54
2025
Q4
$17M Buy
+99,500
New +$15.5M 1.09% 34
2023
Q1
Sell
-221,000
Closed -$9.29M 134
2022
Q4
$9.29M Buy
221,000
+104,000
+89% +$4.35M 0.56% 64
2022
Q3
$4.28M Sell
117,000
-115,000
-50% -$5.12M 0.29% 109
2022
Q2
$9.89M Hold
232,000
0.74% 54
2022
Q1
$12.5M Hold
232,000
0.6% 62
2021
Q4
$16.7M Hold
232,000
0.73% 53
2021
Q3
$13.2M Hold
232,000
0.68% 56
2021
Q2
$15.1M Hold
232,000
0.76% 48
2021
Q1
$13.8M Buy
232,000
+17,000
+8% +$926K 0.91% 34
2020
Q4
$10.2M Buy
215,000
+155,000
+258% +$6.52M 0.74% 46
2020
Q3
$1.99M Buy
+60,000
New +$2.07M 0.16% 71

Other funds holding LRCX

Rheos Capital Works's LRCX Position: Q1 2026 in Review

Rheos Capital Works reduced its Lam Research (LRCX) stake by 52% in Q1 2026, selling an estimated $11.6M and leaving 47,500 shares worth $10.1M. The position accounts for 0.68% of the portfolio, ranked #54.

Rheos Capital Works first reported a position in LRCX in Q3 2020 and has held it in 12 quarters since. The position peaked at $17M in Q4 2025. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Rheos Capital Works held 47,500 shares of Lam Research worth $10.1M as of Q1 2026.
  • Rheos Capital Works sold 52,000 Lam Research shares in Q1 2026, an estimated $11.6M.
  • Lam Research made up 0.68% of Rheos Capital Works's portfolio in Q1 2026, its #54 holding.
  • Rheos Capital Works first reported a position in Lam Research in Q3 2020 and has held it in 12 quarters since.
  • Rheos Capital Works's Lam Research position peaked at $17M in Q4 2025.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Rheos Capital Works's 13F filing for Q1 2026, filed 8 May 2026.